Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/02/2022 | 26.76% | Wedbush | → $4.5 | Initiates Coverage On | → Outperform |
| 08/18/2022 | 69.01% | Piper Sandler | $9 → $6 | Maintains | Overweight |
| 08/18/2022 | 322.54% | Cantor Fitzgerald | $19 → $15 | Maintains | Overweight |
| 03/24/2022 | 153.52% | Piper Sandler | $14 → $9 | Maintains | Overweight |
| 11/15/2021 | 435.21% | Cantor Fitzgerald | $12 → $19 | Maintains | Overweight |
| 11/03/2021 | 238.03% | Cantor Fitzgerald | $12.65 → $12 | Maintains | Overweight |
| 08/05/2021 | 280.28% | Cantor Fitzgerald | $21.5 → $13.5 | Maintains | Overweight |
| 07/07/2021 | 914.08% | Jefferies | → $36 | Initiates Coverage On | → Buy |
| 01/20/2021 | 491.55% | Cantor Fitzgerald | $18 → $21 | Maintains | Overweight |
| 11/19/2020 | 407.04% | Cantor Fitzgerald | $16 → $18 | Maintains | Overweight |
| 10/30/2020 | 350.7% | Cantor Fitzgerald | $15 → $16 | Maintains | Overweight |
| 08/21/2020 | 322.54% | Cantor Fitzgerald | $11 → $15 | Maintains | Overweight |
| 06/12/2020 | 18.31% | Needham | → $4.2 | Initiates Coverage On | → Hold |
| 05/29/2020 | 209.86% | Cantor Fitzgerald | $9.5 → $11 | Maintains | Overweight |
| 05/27/2020 | 167.61% | Cantor Fitzgerald | $8 → $9.5 | Maintains | Overweight |
| 04/28/2020 | 125.35% | Cantor Fitzgerald | $10 → $8 | Maintains | Overweight |
| 03/30/2020 | 181.69% | Cantor Fitzgerald | $12 → $10 | Maintains | Overweight |
| 02/14/2020 | 238.03% | Cantor Fitzgerald | → $12 | Initiates Coverage On | → Overweight |
| 09/13/2019 | 294.37% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
| 08/13/2019 | 209.86% | Piper Sandler | → $11 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/02/2022 | 26.76% | 韋德布什 | → $4.5 | 開始承保 | →跑贏大盤 |
| 08/18/2022 | 69.01% | 派珀·桑德勒 | $9 → $6 | 維護 | 超重 |
| 08/18/2022 | 322.54% | 康託·菲茨傑拉德 | $19 → $15 | 維護 | 超重 |
| 03/24/2022 | 153.52% | 派珀·桑德勒 | $14 → $9 | 維護 | 超重 |
| 11/15/2021 | 435.21% | 康託·菲茨傑拉德 | $12 → $19 | 維護 | 超重 |
| 11/03/2021 | 238.03% | 康託·菲茨傑拉德 | $12.65 → $12 | 維護 | 超重 |
| 08/05/2021 | 280.28% | 康託·菲茨傑拉德 | $21.5 → $13.5 | 維護 | 超重 |
| 07/07/2021 | 914.08% | 傑富瑞 | → $36 | 開始承保 | →購買 |
| 01/20/2021 | 491.55% | 康託·菲茨傑拉德 | $18 → $21 | 維護 | 超重 |
| 11/19/2020 | 407.04% | 康託·菲茨傑拉德 | $16 → $18 | 維護 | 超重 |
| 10/30/2020 | 350.7% | 康託·菲茨傑拉德 | $15 → $16 | 維護 | 超重 |
| 08/21/2020 | 322.54% | 康託·菲茨傑拉德 | $11 → $15 | 維護 | 超重 |
| 06/12/2020 | 18.31% | 李約瑟 | → $4.2 | 開始承保 | →保留 |
| 05/29/2020 | 209.86% | 康託·菲茨傑拉德 | $9.5 → $11 | 維護 | 超重 |
| 05/27/2020 | 167.61% | 康託·菲茨傑拉德 | $8 → $9.5 | 維護 | 超重 |
| 04/28/2020 | 125.35% | 康託·菲茨傑拉德 | $10 → $8 | 維護 | 超重 |
| 03/30/2020 | 181.69% | 康託·菲茨傑拉德 | $12 → $10 | 維護 | 超重 |
| 02/14/2020 | 238.03% | 康託·菲茨傑拉德 | → $12 | 開始承保 | →超重 |
| 09/13/2019 | 294.37% | 考恩公司 | → $14 | 開始承保 | →跑贏大盤 |
| 08/13/2019 | 209.86% | 派珀·桑德勒 | → $11 | 開始承保 | →超重 |
What is the target price for Cresco Labs (CRLBF)?
Cresco Labs(CRLBF)的目標價是多少？
The latest price target for Cresco Labs (OTCQX: CRLBF) was reported by Wedbush on December 2, 2022. The analyst firm set a price target for $4.50 expecting CRLBF to rise to within 12 months (a possible 26.76% upside). 4 analyst firms have reported ratings in the last year.
韋德布什於2022年12月2日報道了Cresco Labs(OTCQX：CRLBF)的最新目標價。這家分析公司將目標價定為4.50美元，預計CRLBF將在12個月內升至(可能上漲26.76%)。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Cresco Labs (CRLBF)?
Cresco Labs(CRLBF)的最新分析師評級是多少？
The latest analyst rating for Cresco Labs (OTCQX: CRLBF) was provided by Wedbush, and Cresco Labs initiated their outperform rating.
Cresco Labs(OTCQX：CRLBF)的最新分析師評級是由韋德布什提供的，Cresco Labs啟動了他們的強於大盤的評級。
When is the next analyst rating going to be posted or updated for Cresco Labs (CRLBF)?
Cresco Labs(CRLBF)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cresco Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cresco Labs was filed on December 2, 2022 so you should expect the next rating to be made available sometime around December 2, 2023.
分析師在進行了廣泛的研究後得出了股票評級，這些研究包括查看公開的財務報表，與Cresco Labs的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Cresco Labs的上一次評級是在2022年12月2日提交的，所以你應該預計下一次評級將在2023年12月2日左右的某個時候公佈。
Is the Analyst Rating Cresco Labs (CRLBF) correct?
分析師對Cresco Labs(CRLBF)的評級正確嗎？
While ratings are subjective and will change, the latest Cresco Labs (CRLBF) rating was a initiated with a price target of $0.00 to $4.50. The current price Cresco Labs (CRLBF) is trading at is $3.55, which is within the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但Cresco Labs(CRLBF)的最新評級是以0.00美元至4.50美元的目標價啟動的。Cresco Labs(CRLBF)目前的交易價格為3.55美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。